Skip to main content
. 2021 May 3;45(4):253–260. doi: 10.1080/01658107.2021.1887289

Table 1.

Symptoms and examination findings

Pt Sex Age Eye Previous or current medication PPVAL ONSS Brain MRI History of migraine Previous diagnosis Quality of pain Time course of pain BCVA in
affected eye on presentation
Final BCVA Ishihara test presentation – final visit RAPD Therapy Improvement with cycloplegic drops
1 F 18 OD None Yes None Normal No Retrobulbar ON Throbbing 6–8 hours per day, 2–4 days per week 6/18 6/6 5/12 – 12/12 No amitriptyline Not given
2 M 25 OD None Yes Nausea Normal Yes Retrobulbar ON Throbbing 12 hours, 1–2 days per week 6/36 6/6 2/12 – 12/12 No amitriptyline Not given
3 F 19 OS NSAIDs Yes Malaise and headache Normal No Retrobulbar ON Throbbing 1–2 hours, 1 day per week 6/9 6/6 5/12 – 12/12 No NSAIDs Yes
4 F 45 OD NSAIDs Yes None Normal NO Retrobulbar ON Sharp Constant, 2–5 days per week CF 6/6 TP – 12/12 No NSAIDs Yes

BCVA = Best corrected visual acuity; MRI = Magnetic resonance imaging; NSAIDs = Non-steroidal anti-inflammatory drugs, OD = Right eye; ON = Optic neuritis; ONSS = Other neurological or systemic symptoms; OS = Left eye; PPVAL = Photophobia, pain and visual acuity loss; Pt = Patient; RAPD = relative afferent pupil defect; TP = Test plate.